Immunolocalisation of P2Y Receptors in the Rat Eye
Overview
Authors
Affiliations
Nucleotides present an important role in ocular physiology which has been demonstrated by recent works that indicate their involvement in many ocular processes. P2Y are important among P2 receptors since they can control tear production, corneal wound healing, aqueous humour dynamics and retinal physiology. Commercial antibodies have allowed us to investigate the distribution of P2Y receptors in the cornea, anterior and posterior chamber of the eye and retina. The P2Y(1) receptor was present mainly in cornea, ciliary processes, and trabecular meshwork. The P2Y(2) receptors were present in cornea, ciliary processes and retinal pigmented epithelium. P2Y(4) was present in cornea, ciliary processes, photoreceptors, outer plexiform layer and ganglion cell layer. The P2Y(6) presented almost an identical distribution as the P2Y(4) receptor. The P2Y(11) was also detectable in the retinal pigmented epithelium. The detailed distribution of the receptors clearly supports the recent findings indicating the relevant role of nucleotides in the ocular function.
Targeting purinergic receptors to attenuate inflammation of dry eye.
Wang J, Fan H, Song J Purinergic Signal. 2022; 19(1):199-206.
PMID: 35218451 PMC: 9984584. DOI: 10.1007/s11302-022-09851-9.
Carpena-Torres C, Pintor J, Huete-Toral F, Martin-Gil A, Rodriguez-Pomar C, Martinez-Aguila A Int J Mol Sci. 2021; 22(21).
PMID: 34769429 PMC: 8584318. DOI: 10.3390/ijms222111999.
Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma.
Fonseca B, Martinez-Aguila A, Perez de Lara M, Miras-Portugal M, Gomez-Villafuertes R, Pintor J Front Pharmacol. 2017; 8:719.
PMID: 29085298 PMC: 5649148. DOI: 10.3389/fphar.2017.00719.
Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.
Shinozaki Y, Kashiwagi K, Namekata K, Takeda A, Ohno N, Robaye B JCI Insight. 2017; 2(19).
PMID: 28978804 PMC: 5841869. DOI: 10.1172/jci.insight.93456.
Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma.
Fonseca B, Martinez-Aguila A, Perez de Lara M, Pintor J Purinergic Signal. 2016; 13(2):171-177.
PMID: 27848070 PMC: 5432477. DOI: 10.1007/s11302-016-9547-y.